Bluejay Diagnostics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Bluejay Diagnostics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Acton
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BJDX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001704287
- EIN
- 47-3552922
Board of directors
-
Donald R. Chase · DirectorSince 2023
-
Douglas Clark Wurth · DirectorSince 2023
-
Fred S. Zeidman · DirectorSince 2023
-
Gary G. Gemignani · DirectorSince 2023
-
Indranil Dey · Director · President and CEOSince 2023
-
Svetlana Dey · DirectorSince 2023
Chief executives
Indranil Dey
· President and CEO
Dates unknown
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
89.8%
-
89.8%
-
89.8%
Board connections
1 of this board's directors also sit on 1 other board.
- via Fred S. Zeidman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $221,711
- 6 purchases by 6 insiders
- Sold, last 12 months
- $48,913
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Indranil Dey Director, Officer (President and CEO) | Grant or award | +28,000 | — | — |
| Jul 10, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −34,938 | $1.40 | $48,913 |
| Jul 9, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +64,047 | $1.51 | $96,711 |
| Mar 14, 2026 | Douglas Clark Wurth Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Indranil Dey Director, Officer (President and CEO) | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Donald R. Chase Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Fred S. Zeidman Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Svetlana Dey Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Dec 13, 2023 | Svetlana Dey Director | Open-market purchase | +500 | $3.07 | $1,535 |
| Dec 13, 2023 | Indranil Dey Director, Officer (President and CEO), 10% owner | Open-market purchase | +500 | $3.27 | $1,635 |
| Mar 28, 2023 | Indranil Dey Director, Officer (President and CEO) | Grant or award | +2,000 | $0.44 | $880 |
| Mar 27, 2023 | Indranil Dey Director, Officer (President and CEO) | Grant or award | +8,000 | $0.44 | $3,520 |
| Mar 24, 2023 | Svetlana Dey Director | Grant or award | +10,000 | $0.44 | $4,400 |
| Feb 1, 2023 | Gary G. Gemignani Director | Grant or award | +27,500 | $0.44 | $12,100 |
| Feb 1, 2023 | Donald R. Chase Director | Grant or award | +27,500 | $0.44 | $12,100 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.